FDG PET-MRI for the Diagnosis of Spinal Cord Lesions

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 21, 2018

Primary Completion Date

May 7, 2024

Study Completion Date

May 7, 2024

Conditions

Spinal Cord Neoplasm

Interventions

DRUG

Fludeoxyglucose F-18

Given IV

DEVICE

Magnetic Resonance Imaging

Undergo PET-MRI

PROCEDURE

Positron Emission Tomography

Undergo PET-MRI

Trial Locations (1)

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT04219969 - FDG PET-MRI for the Diagnosis of Spinal Cord Lesions | Biotech Hunter | Biotech Hunter